Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 1.17% | 60.59 | 0.0% | $1954.52m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.95% | 598.54 | 2.5% | $1194.19m | |
| GILD | Gilead Sciences, Inc. | 4.22% | 77.54 | 1.0% | $991.43m | |
| AMGN | Amgen, Inc. | -0.05% | 220.88 | 1.3% | $628.89m | |
| NVAX | Novavax, Inc. | 0.93% | 44.66 | 102.0% | $620.64m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.51% | 272.82 | 1.9% | $540.62m | |
| ILMN | Illumina, Inc. | 0.02% | 358.40 | 3.5% | $384.32m | |
| BIIB | Biogen, Inc. | -0.98% | 299.65 | 1.6% | $368.00m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.08% | 113.68 | 2.0% | $250.86m | |
| SRNE | Sorrento Therapeutics, Inc. | -6.76% | 3.86 | 1.8% | $246.90m | |
| SGEN | Seattle Genetics, Inc. | -2.98% | 150.43 | 6.1% | $229.28m | |
| A | Agilent Technologies, Inc. | 0.70% | 91.12 | 1.6% | $215.04m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -3.33% | 107.51 | 4.3% | $187.14m | |
| MGNX | MacroGenics, Inc. | -2.52% | 20.48 | 6.2% | $164.68m | |
| INCY | Incyte Corp. | -5.09% | 93.80 | 2.5% | $153.77m |
Company Profile
Iterum Therapeutics Plc is a pharmaceutical company which engages in the development and commercialization of sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available. Sulopenem is a potent, thiopenem antibiotic delivered intravenously which is active against bacteria that belong to the group of organisms known as gram-negatives and cause urinary tract and intra-abdominal infections. It operates through the Ireland and Unites States geographical segments. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.